Accelerate Diagnostics, Inc.
AXDX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -3% | -5.4% | 8.2% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 23.1% | 21.1% | 25.9% | -3.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -287% | -412.7% | -437.6% | -505.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -427.8% | -511% | -490.1% | -659.5% |
| EPS Diluted | -2.15 | -4.94 | -7.61 | -12.59 |
| % Growth | 56.5% | 35.1% | 39.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |